These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 17006905)

  • 1. Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.
    Nattermann J; Zimmermann H; Iwan A; von Lilienfeld-Toal M; Leifeld L; Nischalke HD; Langhans B; Sauerbruch T; Spengler U
    Hepatology; 2006 Oct; 44(4):945-54. PubMed ID: 17006905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5.
    Nattermann J; Nischalke HD; Feldmann G; Ahlenstiel G; Sauerbruch T; Spengler U
    J Viral Hepat; 2004 Nov; 11(6):519-26. PubMed ID: 15500552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein: correlation with treatment response in hepatitis C virus-infected patients.
    Hofmann WP; Sarrazin C; Kronenberger B; Schönberger B; Bruch K; Zeuzem S
    J Infect Dis; 2003 Mar; 187(6):982-7. PubMed ID: 12660945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in the putative HCV-E2 CD81 binding regions and correlation with cell surface CD81 expression.
    Kronenberger B; Sarrazin C; Hofmann WP; von Wagner M; Herrmann E; Welsch C; Elez R; Rüster B; Piiper A; Zeuzem S
    J Viral Hepat; 2004 Jul; 11(4):310-8. PubMed ID: 15230853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-derived dendritic cells from chronic HCV patients are not infected but show an immature phenotype and aberrant cytokine profile.
    Gelderblom HC; Nijhuis LE; de Jong EC; te Velde AA; Pajkrt D; Reesink HW; Beld MG; van Deventer SJ; Jansen PL
    Liver Int; 2007 Sep; 27(7):944-53. PubMed ID: 17696933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infection and dysfunction of circulating blood dendritic cells and their subsets in chronic hepatitis C virus infection.
    Tsubouchi E; Akbar SM; Horiike N; Onji M
    J Gastroenterol; 2004 Aug; 39(8):754-62. PubMed ID: 15338369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C.
    Longman RS; Talal AH; Jacobson IM; Rice CM; Albert ML
    J Infect Dis; 2005 Aug; 192(3):497-503. PubMed ID: 15995965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD81 expression on CD19+ peripheral blood lymphocytes is associated with chronic HCV disease and increased risk for HCV infection: a putative role for inflammatory cytokines.
    D'Agosto G; Trento E; Nosotti L; Bordignon V; Battista M; Prignano G; Pimpinelli F; Biolcati G; Macrì A; Palamara G; Miglioresi L; Morrone A; Di Carlo A; Cordiali-Fei P; Ensoli F
    J Biol Regul Homeost Agents; 2009; 23(3):155-64. PubMed ID: 19828092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced CC chemokine receptor (CCR) 1 and CCR5 surface expression on peripheral blood T lymphocytes from patients with chronic hepatitis C infection.
    Lichterfeld M; Leifeld L; Nischalke HD; Rockstroh JK; Hess L; Sauerbruch T; Spengler U
    J Infect Dis; 2002 Jun; 185(12):1803-7. PubMed ID: 12085329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of antigen-presenting cell functions by alcohol: implications for hepatitis C virus infection.
    Szabo G; Dolganiuc A; Mandrekar P; White B
    Alcohol; 2004 Jul; 33(3):241-9. PubMed ID: 15596093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
    Ciesek S; Liermann H; Hadem J; Greten T; Tillmann HL; Cornberg M; Aslan N; Manns MP; Wedemeyer H
    J Viral Hepat; 2008 Mar; 15(3):200-11. PubMed ID: 18233993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive inhibition of dendritic cell allostimulatory capacity by alcohol and hepatitis C is not restored by DC maturation and involves abnormal IL-10 and IL-2 induction.
    Dolganiuc A; Kodys K; Kopasz A; Marshall C; Mandrekar P; Szabo G
    Alcohol Clin Exp Res; 2003 Jun; 27(6):1023-31. PubMed ID: 12824825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(I:C) and lipopolysaccharide innate sensing functions of circulating human myeloid dendritic cells are affected in vivo in hepatitis C virus-infected patients.
    Rodrigue-Gervais IG; Jouan L; Beaulé G; Sauvé D; Bruneau J; Willems B; Sékaly RP; Lamarre D
    J Virol; 2007 Jun; 81(11):5537-46. PubMed ID: 17376921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins.
    Allander T; Forns X; Emerson SU; Purcell RH; Bukh J
    Virology; 2000 Nov; 277(2):358-67. PubMed ID: 11080483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulation by hepatitis C virus-derived proteins: targeting human dendritic cells by multiple mechanisms.
    Krishnadas DK; Ahn JS; Han J; Kumar R; Agrawal B
    Int Immunol; 2010 Jun; 22(6):491-502. PubMed ID: 20410260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C).
    Echeverría I; Zabaleta A; Silva L; Díaz-Valdés N; Riezu-Boj JI; Lasarte JJ; Borrás-Cuesta F; Civeira MP; Prieto J; Sarobe P
    J Viral Hepat; 2008 Nov; 15(11):782-9. PubMed ID: 18637068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
    Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections.
    Tseng CT; Miskovsky E; Houghton M; Klimpel GR
    Hepatology; 2001 May; 33(5):1312-20. PubMed ID: 11343261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.
    Zeremski M; Petrovic LM; Talal AH
    J Viral Hepat; 2007 Oct; 14(10):675-87. PubMed ID: 17875002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.